Articles with public access mandates - Christina Fotopoulou - UK Medical Research CouncilLearn more
NoteFor this mandate, articles should be available from specific locations.
Not available based on mandate: 2
A review of thoracic and mediastinal cytoreductive techniques in advanced ovarian cancer: extending the boundaries
S Nasser, M Kyrgiou, J Krell, D Haidopoulos, R Bristow, C Fotopoulou
Annals of Surgical Oncology 24, 3700-3705, 2017
A method for voltage measurements of cancerous vs non-cancerous omentum
W Wu, K Vitharana, T Gorgy, A Paterson, P Cunnea, H Gabra, ...
2015 37th Annual International Conference of the IEEE Engineering in …, 2015
Available based on mandate: 13
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ...
Nature reviews Cancer 15 (11), 668-679, 2015
Copy number signatures and mutational processes in ovarian carcinoma
G Macintyre, TE Goranova, D De Silva, D Ennis, AM Piskorz, M Eldridge, ...
Nature genetics 50 (9), 1262-1270, 2018
Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study
JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, PGDME, ...
Journal of Clinical Oncology 39 (1), 66-78, 2021
A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic-and molecular-phenotypes of epithelial ovarian cancer
H Lu, M Arshad, A Thornton, G Avesani, P Cunnea, ED Curry, F Kanavati, ...
Nature communications 10 (1), 764, 2019
High temporal resolution delayed analysis of clinical microdialysate streams
SAN Gowers, K Hamaoui, P Cunnea, S Anastasova, VF Curto, ...
Analyst 143 (3), 715-724, 2018
Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer
H Lu, P Cunnea, K Nixon, N Rinne, EO Aboagye, C Fotopoulou
British journal of cancer 124 (7), 1286-1293, 2021
Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma—experience of the BriTROC consortium
T Goranova, D Ennis, AM Piskorz, G Macintyre, LA Lewsley, J Stobo, ...
British journal of cancer 116 (10), 1294-1301, 2017
Diagnostic accuracy of FEC-PET/CT, FDG-PET/CT, and diffusion-weighted MRI in detection of nodal metastases in surgically treated endometrial and cervical carcinoma
AG Rockall, TD Barwick, W Wilson, N Singh, N Bharwani, A Sohaib, ...
Clinical Cancer Research 27 (23), 6457-6466, 2021
Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer
C Alifrangis, A Thornton, C Fotopoulou, J Krell, H Gabra
Gynecologic Oncology Reports 18, 42-44, 2016
Clinical value of bioelectrical properties of cancerous tissue in advanced epithelial ovarian cancer patients
P Cunnea, T Gorgy, K Petkos, SAN Gowers, H Lu, C Morera, W Wu, ...
Scientific Reports 8 (1), 14695, 2018
Novel technologies in the treatment and monitoring of advanced and relapsed epithelial ovarian cancer
P Cunnea, S Gowers, JE Moore, E Drakakis, M Boutelle, C Fotopoulou
Convergent science physical oncology 3 (1), 013002, 2017
Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy
P Carter, C Alifrangis, B Cereser, P Chandrasinghe, LDB Belluz, ...
Oncotarget 9 (5), 6007, 2018
End-to-End Integrative Segmentation and Radiomics Prognostic Models Improve Risk Stratification of High-Grade Serous Ovarian Cancer: A Retrospective Multi-Cohort Study
LANCET DIGITAL HEALTH, K Linton-Reid, G Wengert, H Lu, ...
medRxiv, 2023.04. 26.23289155, 2023
Publication and funding information is determined automatically by a computer program